Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
How much is this realistically worth? Have we got any decent estimates yet?
"I'm young enough to wait"
Sooooo.......Timster.....ever seen a grown man naked?
(For those too young to remember the movie quote (Airplane - 1980)
https://youtu.be/wfgO90yGusI
Cj62...I wouldn't rule out some very interesting updates regarding the company before end Q1...she has to be seen to explain/uncover the real reason behind the 0.50 Placing and what has been decided for DX going forward...once this is done and dusted then the stage will be set for the data release and trial extension etc.
Russell if you actually understand the presentation, i cant see why you would be considering selling, unless you are a day trader
CC closed with...'It has the potential to change the way we treat cancer...'
Other takeaways...
Data already harvested/released HAS unlocked the pipeline and numerous discussions are underway.
Eliot and CC have worked together before.
FAP high or medium doesn't appear to be a big issue...Precision still targets alsmost as if there's no difference.
Much more data being harvested than has been divulged so far.
Much of today's Presentation has already been covered and was going over old ground but some nice little gems in there too.
Roll on Q2
Very busy man, new and existing discussions on going, seems inevitable 3rd party deals will be done on more toxic warheads this year. Everything on the table was also an interesting comment suggests they might also look at deals on the current lead assets, if they can develop in-house more toxic warheads for the future.
Last post aimed at Wynbore...
Specifically
Yes and who might be beefing up the Board...Fund investor(s)...
Now I'm more convinced than ever that we are going to see Levicept Fund Investors coming on board and DX Spun Off.
Looking forward to second half of the year.
2WD is on schedule
Cash runway secure
Science is going to change the way cancer is treated.
Maybe needs a little patience. H2 will be huge.
Classic Windy FUD when he’s out …. BS as answer was in RNS 👇
“Why was there no news on 2WD. Is it running behind schedule?”
TG is a goner , she's not messing about is she . If she is to be believed H2 24 should be extremely interesting but i am going for December
Wynbore he said post them in the general forum not clog up this one with your garbage
A report call, to go through the business numbers, with just one, half-hearted question regarding the incredible low fundraise.
With the rest of the clock run down on scientific questions. Which just made the company sound like a bottomless pit of money and time.
This was corporate results call not a scientific update, share price not mentioned once.
The highlight is pre|CISION works and for mid and high FAP expression there is no real difference.
if you can hold and wait then this will surely get bought or license.
I'm young enough to wait
I'd be amazed if there aren't many small investors like myself listening to try and decide whether to keep or sell their holdings.
Give it some time Timster. Once she's been in Yorkshire a while it'll change. Soon it'll be 'I say what I like and I like what I bloody well say'
Idiot russell. "Obviously looking at the buys v sells since the presentation began, not many people positive".....that's because maybe people are busy listening to the presentation.
I suppose that depends on who you think the sellers are Russell. and actually there are relatively few transactions
Timster that is a great skill for a CEO
I'm glad you put that, its not just me, a masterclass in twadle
everyone is free to trade as they wish, i have no problem with that. i do however have a problem with hearing constant updates about an individuals trading strategy, particularly when said individual flips their narrative based on their position. if everyone did this we would have 100,000 posts on here every day just stating "i have bought", "i have sold". just keep it to yourself you narcissistic **** and **** off. if you have an opinion about this company this is great, please state this, but if you flip your opinion every few days, also **** off.
CC does well at not really answering questions to be fair.
Obviously looking at the buys v sells since the presentation began, not many people positive.
"Cant understand why anyone is selling here."
because we have to wait till H2 for exciting stuff to happen and that's way too long for the rainbow chasers
Cant understand why anyone is selling here.
Nothing is off the table
Chief business offer is very busy, multiple conversations ongoing.
Therapeutics - move to next chapter, pipeline of assets, precision can be implemented in many ways
Financing - answers coming soon
Diagnostics - maximize value - plan coming soon
Evolution of the board - Critical competencies required to go into next chapter
Presentation received very well received by scientists, oncologists who had ideas about choice of warheads.
Major pharma and biotech companies triggering new conversations.
Patient advocates asking about next steps for AVA6000 - this is key to enrolling patients for clinical trials